Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Therapie
|
June 3, 2005
[ATC and EphMRA classifications: evolution from 1996 to 2003 and comparative analysis]
Corinne Tollier, Isabelle Fusier, Marie-Caroline Husson
Pharmacy World & Science : PWS
|
August 13, 2005
Infovigilance: reporting errors in official drug information sources
Isabelle Fusier, Corinne Tollier, Marie-Caroline Husson
Pharmacy World & Science : PWS
|
September 11, 2003
Medicines containing pharmaceutical excipients with known effects: a French review
Isabelle Fusier, Corinne Tollier, Marie Caroline Husson
Pharmacoeconomics
|
July 15, 2016
Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience
François Bocquet, Anaïs Loubière, Isabelle Fusier, et al.
Applied Health Economics and Health Policy
|
September 6, 2014
Biosimilar versus patented erythropoietins: learning from 5 years of European and Japanese experience
François Bocquet, Pascal Paubel, Isabelle Fusier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 13, 2016
Defibrotide in Severe Sinusoidal Obstruction Syndrome: Medicine and Economic Issues
Julie Steelandt, François Bocquet, Anne-Laure Cordonnier, et al.
Applied Health Economics and Health Policy
|
March 1, 2014
Biosimilar granulocyte colony-stimulating factor uptakes in the EU-5 markets: a descriptive analysis
François Bocquet, Pascal Paubel, Isabelle Fusier, et al.
Journal of Comparative Effectiveness Research
|
March 15, 2018
Economic and organizational impact of the changing hospital funding practices of erythropoiesis-stimulating agents on the management of care of dialysis patients in France
Carole Therasse, Isabelle Fusier, Anne-Laure Cordonnier, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Therapie
|
June 3, 2005
[ATC and EphMRA classifications: evolution from 1996 to 2003 and comparative analysis]
Corinne Tollier, Isabelle Fusier, Marie-Caroline Husson
Pharmacy World & Science : PWS
|
August 13, 2005
Infovigilance: reporting errors in official drug information sources
Isabelle Fusier, Corinne Tollier, Marie-Caroline Husson
Pharmacy World & Science : PWS
|
September 11, 2003
Medicines containing pharmaceutical excipients with known effects: a French review
Isabelle Fusier, Corinne Tollier, Marie Caroline Husson
Pharmacoeconomics
|
July 15, 2016
Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience
François Bocquet, Anaïs Loubière, Isabelle Fusier, et al.
Applied Health Economics and Health Policy
|
September 6, 2014
Biosimilar versus patented erythropoietins: learning from 5 years of European and Japanese experience
François Bocquet, Pascal Paubel, Isabelle Fusier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 13, 2016
Defibrotide in Severe Sinusoidal Obstruction Syndrome: Medicine and Economic Issues
Julie Steelandt, François Bocquet, Anne-Laure Cordonnier, et al.
Applied Health Economics and Health Policy
|
March 1, 2014
Biosimilar granulocyte colony-stimulating factor uptakes in the EU-5 markets: a descriptive analysis
François Bocquet, Pascal Paubel, Isabelle Fusier, et al.
Journal of Comparative Effectiveness Research
|
March 15, 2018
Economic and organizational impact of the changing hospital funding practices of erythropoiesis-stimulating agents on the management of care of dialysis patients in France
Carole Therasse, Isabelle Fusier, Anne-Laure Cordonnier, et al.
Page
of 1